ArticleFrontiers in cardiovascular medicine2025
First-phase ejection fraction is associated with myocardial fibrosis in the pressure overloaded heart.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: First-phase ejection fraction (EF1) has been recently demonstrated to sensitively detect early cardiac systolic dysfunction. However, the value of EF1 in predicting myocardial fibrosis (MF) has not been investigated. This study aimed to explore the relationship between EF1 and MF in the pressure overloaded heart. Methods: The pressure overloaded heart was induced by minimally invasive transverse aortic constriction (MTAC) in rats. Rats in the sham and MTAC groups were equally divided into different time points for examination, respectively. Echocardiography was conducted to validate the success of MTAC model and measure cardiac systolic function parameters. Subsequently, rat hearts underwent Masson's staining to measure the degree of MF. Results: Compared with sham group rats, MTAC group rats exhibited a significantly progressive impairment in EF1 starting from the 2nd week over observational period ( Conclusions: EF1 represents a highly sensitive and non-invasive marker for the early detection of cardiac systolic dysfunction and emerges as a promising indicator for the identification of MF in the early stage of pressure overloaded heart.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.